ArticleNPJ precision oncology2021

Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.

Mayumi Sugita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.